BERNSTEIN HAROLD (President, R&D & CMO) sold 16.14K shares of MAZE THERAPEUTICS, INC. on the open market
Open‑market sale worth $425.5K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/3/2026ACC: 0002050172-26-000032
Officer· President, R&D & CMO
Since Mar 2026
-16.14K
Net shares
Net seller
$425.5K
Total sold
1
Open market trades
0B · 1S
5
Total transactions
36.14K acquired · 52.28K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+16.14K
Price / share
$10.42
Trade value
$168.19K
% of position
New position
9/1/2026
0.00→16.14K
Common Stock
Direct
Shares
−16.14K
Price / share
$26.36
Trade value
$425.51K
% of position
New position
9/1/2026
16.14K→0.00
Common Stock
Direct
Shares
+20K
Price / share
—
Trade value
—
% of position
New position
9/1/2026
0.00→20K
Total
Net shares
+20K
Net value
-$257.32K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/1/2026 | M · Option Exercise | +16.14K | $10.42 | $168.19K | New position | 0.00 | 16.14K |
| Common Stock Direct | 9/1/2026 | S · Sale | −16.14K | $26.36 | $425.51K | New position | 16.14K | 0.00 |
| Common Stock Direct | 9/1/2026 | M · Option Exercise | +20K | — | — | New position | 0.00 | 20K |
| Total | +20K | -$257.32K | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
16.14K shares
Shares
−16.14K
Strike price
10.42
Held after
160.66K
Exercisable
—
9/1/2026
Restricted Stock Units
Direct
Converts to
Common Stock
20K shares
Shares
−20K
Strike price
Held after
20K
Exercisable
—
9/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock16.14K shares | 9/1/2026 | M · Option Exercise | −16.14K | 10.42 | — | 160.66K |
| Restricted Stock Units Direct | Common Stock20K shares | 9/1/2026 | M · Option Exercise | −20K | — | 20K |